Balance Sheet
Cash Flow Statement
AmortizationAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Change in Receivables (2024 - 2025)

Historic Change in Receivables for BioLineRx (BLRX) over the last 2 years, with Q3 2025 value amounting to $78000.0.

  • BioLineRx's Change in Receivables rose 11805.56% to $78000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year change of. This contributed to the annual value of -$2.1 million for FY2024, which is 49162.01% down from last year.
  • BioLineRx's Change in Receivables amounted to $78000.0 in Q3 2025, which was up 11805.56% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, BioLineRx's Change in Receivables registered a high of $1.4 million during Q2 2025, and its lowest value of -$2.5 million during Q1 2024.